Medifast (MED) PT Raised to $239 at DA Davidson Following ICR Conference
Tweet Send to a Friend
DA Davidson analyst Linda Bolton Weiser raised the price target on Medifast (NYSE: MED) to $239.00 (from $205.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
